Alexis Peyroles is the founder of OSE Immunotherapeutics. OSE Immunotherapeutics has raised $21M in total funding. Latest round: IPO. Based in Nantes, France.
Alexis Peyroles is the CEO of OSE Immunotherapeutics, a French clinical-stage listed biotechnology company. He leads the company's development of therapies targeting cancer and autoimmune conditions, including an IL-7 receptor antagonist. Peyroles has been with OSE since its early growth phase, which included a public IPO on Euronext.
Full founder directory · Investor directory · Company funding database · Fundraising library